Retraction: Overexpression of the insulin receptor isoform a promotes endometrial carcinoma cell growth (PLoS ONE (2013) 8:8 (E69001) DOI: 10.1371/journal.pone.0069001);Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wang, Chun Fang ^a   Zhang, Guo ^a   Zhao, Li Jun ^a   Qi, Wen Juan ^a   Li, Xiao Ping ^a   Wang, Jian Liu ^a   Wei, Li Hui ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR A; INSULIN RECEPTOR B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SOMATOMEDIN B; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RECEPTOR GENE; INSULIN RECEPTOR ISOFORM A GENE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR GENE; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION;

MUS MUSCULUS;

ADULT; AGED; ANIMALS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; ENDOMETRIAL NEOPLASMS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84881366287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0260686     Document Type: Erratum

References (21)

1. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, et al. (2005) Endometrial cancer. Lancet. 366: 491-505. doi:10.1016/S0140-6736(05)67063-8. PubMed: 16084259.
2. Giudice J, Leskow FC, Arndt-Jovin DJ, Jovin TM, Jares-Erijman EA, (2011) Differential endocytosis and signaling dynamics of insulin receptor variants IR-A and IR-B. J Cell Sci 124: 801-811. doi:10.1242/jcs.076869. PubMed: 21303927.
3. Moller DE, Yokota A, Caro JF, Flier JS, (1989) Tissue-specifi{ligature}c expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 3: 1263-1269. doi:10.1210/mend-3-8-1263. PubMed: 2779582.
4. Denley A, Bonython ER, Booker GW, Cosgrove LJ, Forbes BE, et al. (2004) Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol Endocrinol 18: 2502-2512. doi:10.1210/me.2004-0183. PubMed: 15205474.
5. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, et al. (1999) Insulin receptor isoformA,a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19: 3278-3288. PubMed: 10207053.
6. Vella V, Pandini G, Sciacca L, Mineo R, Vigneri R, et al. (2002) A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 87: 245-254. doi:10.1210/jc.87.1.245. PubMed: 11788654.
7. Kalli KR, Falowo OI, Bale LK, Zschunke MA, Roche PC, et al. (2002) Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling. Endo-crinology 143: 3259-3267.
8. Sciacca L, Mineo R, Pandini G, Murabito A, Vigneri R, et al. (2002) In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A. Oncogene 21: 8240-8250. doi:10.1038/sj.onc.1206058. PubMed: 12447687.
9. Denley A, Wallace JC, Cosgrove LJ, Forbes BE, (2003) The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review. Horm Metab Res 35: 778-785. doi:10.1055/s-2004-814157. PubMed: 14710358.
10. Ulanet DB, Ludwig DL, Kahn CR, Hanahan D, (2010) Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy. Proceedings of the National Academyof Sciences of the United States of America 107: 10791-10798. PubMed: 20457905.
11. Alvino CL, Ong SC, McNeil KA, Delaine C, Booker GW, et al. (2011) Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II. PLOS ONE 6: e27488. doi:10.1371/journal.pone.0027488. PubMed: 22140443.
12. Shaul YD, Seger R, (2007) The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta 1773: 1213-1226. doi:10.1016/j.bbamcr.2006.10.005. PubMed: 17112607.
13. Lai JP, Sandhu DS, Yu C, Moser CD, Hu C, et al. (2010) Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors. Liver Int 30: 1522-1528. doi:10.1111/j.1478-3231.2010.02336.x. PubMed: 21040406.
14. Hemminki K, Li X, Sundquist J, Sundquist K, (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15: 548-555. doi:10.1634/theoncologist.2009-0300. PubMed: 20479278.
15. Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, et al. (1990) Elevated insulin receptor content in human breast cancer. J Clin Invest 86: 1503-1510. doi:10.1172/JCI114868. PubMed: 2243127.
16. Gallagher EJ, LeRoith D, (2010) The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab 21: 610-618. doi:10.1016/j.tem.2010.06.007. PubMed: 20663687.
17. McGrath M, Lee IM, Buring J, De Vivo I, (2011) Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk. Gynecol Oncol 120(2):: 174-178. doi:10.1016/j.ygyno.2010.10.012. PubMed: 21078522.
18. Garrett JT, Chakrabarty A, Arteaga CL, (2011) Will PI3K pathway inhibitors be effective as single agents in patients with cancer? Oncotarget 2: 1314-1321. PubMed: 22248929.
19. Cantley LC, (2002) The phosphoinositide 3-kinase pathway. Science 296: 1655-1657. doi:10.1126/science.296.5573.1655. PubMed: 12040186.
20. Zhang G, Li X, Zhang L, Zhao L, Jiang J, Wang J, et al. (2010) The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells. Cancer Genet Cytogenet 200: 140-148. doi:10.1016/j.cancergencyto.2010.04.007. PubMed: 20620597.
21. Zhang L, Li X, Zhao L, Zhang L, Zhang G, et al. (2009) Nongenomic effect of estrogen on the MAPK signaling pathway and calcium influx in endometrial carcinoma cells. J Cell Biochem 106(4):: 553-562. doi:10.1002/jcb.22017. PubMed: 19160418.